Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo

被引:265
作者
Suspène, R
Guétard, D
Henry, M
Sommer, P
Wain-Hobson, S
Vartanian, JP
机构
[1] Inst Pasteur, CNRS, Unite Rech Assoc 1930, F-75724 Paris, France
[2] Inst Pasteur, Cell Biol Nucleus Unit, F-75724 Paris, France
关键词
hypermutation; DNA editing;
D O I
10.1073/pnas.0408223102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Because the replication of hepatitis B virus (HBV) proceeds via an obligatory reverse transcription step in the viral capsid, cDNA is potentially vulnerable to editing by cytidine deaminases of the APOBEC3 family. To date only two edited HBV genomes, referred to as G -> A hypermutants, have been described in vivo. Recent work suggested that HBV replication was indeed restricted by APOBEC3G but by a mechanism other than editing. The issue of restriction has been explored by using a sensitive PCR method allowing differential amplification of AT-rich DNA. G -> A hypermutated HBV genomes were recovered from transfection experiments involving APOBEC3B, -3C, -3F, and -3G indicating that all four enzymes were able to extensively deaminate cytidine residues in minus-strand DNA. Unexpectedly, three of the four enzymes (APOBEC3B, -3F, and -3G) deaminated HBV plus-strand DNA as well. From the serum of two of four patients with high viremia, G -> A hypermutated genomes were recovered at a frequency of approximate to 10(-4), indicating that they are, albeit relatively rare, part of the natural cycle of HBV infection. These findings suggest that human APOBEC3 enzymes can impact HBV replication via cytidine deamination.
引用
收藏
页码:8321 / 8326
页数:6
相关论文
共 44 条
[11]   DNA determination mediates innate immunity to retroviral infection [J].
Harris, RS ;
Bishop, KN ;
Sheehy, AM ;
Craig, HM ;
Petersen-Mahrt, SK ;
Watt, IN ;
Neuberger, MS ;
Malim, MH .
CELL, 2003, 113 (06) :803-809
[12]   Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4+ T cells [J].
Janini, M ;
Rogers, M ;
Birx, DR ;
McCutchan, FE .
JOURNAL OF VIROLOGY, 2001, 75 (17) :7973-7986
[13]   An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 [J].
Jarmuz, A ;
Chester, A ;
Bayliss, J ;
Gisbourne, J ;
Dunham, I ;
Scott, J ;
Navaratnam, N .
GENOMICS, 2002, 79 (03) :285-296
[14]   Hypermutation of HIV-1 DNA in the absence of the Vif protein [J].
Lecossier, D ;
Bouchonnet, F ;
Clavel, F ;
Hance, AJ .
SCIENCE, 2003, 300 (5622) :1112-1112
[15]   APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo [J].
Liddament, MT ;
Brown, WL ;
Schumacher, AJ ;
Harris, RS .
CURRENT BIOLOGY, 2004, 14 (15) :1385-1391
[16]   Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging [J].
Luo, K ;
Liu, BD ;
Xiao, ZX ;
Yu, YK ;
Yu, XH ;
Gorelick, R ;
Yu, XF .
JOURNAL OF VIROLOGY, 2004, 78 (21) :11841-11852
[17]   Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts [J].
Mangeat, B ;
Turelli, P ;
Caron, G ;
Friedli, M ;
Perrin, L ;
Trono, D .
NATURE, 2003, 424 (6944) :99-103
[18]   Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif [J].
Mariani, R ;
Chen, D ;
Schröfelbauer, B ;
Navarro, F ;
König, R ;
Bollman, B ;
Münk, C ;
Nymark-McMahon, H ;
Landau, NR .
CELL, 2003, 114 (01) :21-31
[19]   HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation [J].
Marin, M ;
Rose, KM ;
Kozak, SL ;
Kabat, D .
NATURE MEDICINE, 2003, 9 (11) :1398-1403
[20]   G to A hypermutation of hepatitis B virus [J].
Noguchi, C ;
Ishino, H ;
Tsuge, M ;
Fujimoto, Y ;
Imamura, M ;
Takahashi, S ;
Chayama, K .
HEPATOLOGY, 2005, 41 (03) :626-633